Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...

Inspire Medical Systems has reported a significant 84% rise in Q1 2023 revenue, reaching $127.9 million, driven by its innovative treatments for Obstructive Sleep Apnea. The company has received FDA ...

CANTON – Aultman is now offering Inspire therapy, a new obstructive sleep apnea (OSA) treatment option for those who cannot use continuous positive airway pressure (CPAP) therapy. This new implanted ...

A new study published in the Journal of the American Medical Association found that obstructive sleep apnea could be linked ...

Doctors at ENT Head & Neck Specialists have completed the practice’s 100th Berks County procedure of Inspire — an FDA-approved obstructive sleep apnea treatment option for people who cannot use ...

Waking up from a good night’s sleep, ready to take on the day, is a feeling we all strive for. Dr. Roland Gerencer is an Ear, Nose, and Throat physician for Health Specialists of New Mexico ...

Maple Grove medical device maker Inspire Medical has filed for an initial public offering of stock to raise up to $86.3 million. Inspire Medical is an 11-year-old privately held company that makes an ...

Medicare may cover Inspire, a device to treat sleep apnea, if it is medically necessary. A doctor needs to demonstrate that people meet certain criteria and CPAP therapy has been ineffective. Inspire ...

At one point of time, there were at least three companies in the U.S. aiming to win FDA approval to launch an implantable neurostimulator to treat obstructive sleep apnea. Then there were just two.

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...

It's not just you. A large percentage of Americans are not getting a good night's sleep, in many cases because of a sleep disorder — and a growing number of Twin Cities companies are developing new ...